Table 5.

Clinical outcomes

Procedure success (%)	117 (100.0)
Periprocedural cardiac biomarker increase (%)	1 (0.9)
In-hospital MACE (%)	0 (0.0)
Post TIMI 3 flow (%)	116 (99.1)
Temporal SB occlusion (%)	0 (0.0)
Side branch loss (%)	0 (0.0)
SB TIMI flow after MV stenting
0–1 (%)	0 (0.0)
2 (%)	1 (0.9)
3 (%)	116 (99.1)
Dissection
Proximal stent edge (%)	0 (0.0)
Distal stent edge (%)	0 (0.0)
SB ostium (%)	1 (0.9)
SB stenting	0 (0.0)
Balloon or wire entrapment	0 (0.0)

Data are presented as n (%)

MACE, major adverse cardiovascular events; MV, main vessel; SB, side branch; TIMI, thrombolysis in myocardial infarction